La neutropenia autoimmune primitiva del bambino

1. Martino R, Muñiz-Díaz E, Arilla M, et al. Combined autoimmune cytopenias. Haematologica 1995;80:305-10. 2. Bruin MC, von dem Borne AE, Tamminga RY, Kleijer M, Buddelmeijer L, de Haas M. Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood 1999;94:1797-802. 3. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood 1998;91:181-6. 4. Wang LY, Wang CL, Chu CC, et al. Primary autoimmune neutropenia in children in Taiwan. Transfusion 2009;49:1003-6. 5. Capsoni F, Sarzi-Puttini P, Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res Ther 2005;7:208-14. 6. Shastri KA, Logue GL. Autoimmune neutropenia. Blood 1993;81:1984-95. 7. Nakamura K, Miki M, Mizoguchi Y, Karakawa S, Sato T, Kobayashi M. Deficiency of regulatory T cells in children with autoimmune neutropenia. Br J Haematol 2009;145: 642-7. 8. Blaschke J, Goeken NE, Thompson JS, Dick FR, Gingrich RD. Acquired agranulocytosis with granulocyte specific cytotoxic autoantibody. Am J Med 1979;66:862-6. 9. Calhoun DA, Rimsza LM, Burchfield DJ, et al. Congenital autoimmune neutropenia in two premature neonates. Pediatrics 2001;108:181-4. 10. Lalezari P, Khorshidi M, Petrosova M. Autoimmune neutropenia of infancy. J Pediatr 1986;109:764-9. 11. Neglia JP, Watterson J, Clay M, et al. Autoimmune neutropenia of infancy and early childhood. Pediatr Hematol Oncol 1993;10: 369-76. 12. Bux J, Hofmann C, Welte K. Serum G-CSF levels are not increased in patients with antibody- induced neutropenia unless they are suffering from infectious diseases. Br J Haematol 1999;105:616-7. 13. Bux J, Kissel K, Nowak K, Spengel U, Mueller-Eckhardt C. Autoimmune neutropenia: clinical and laboratory studies in 143 patients. Ann Hematol 1991;63:249-52. 14. Bux J, Kissel K, Nowak K, Spengel U, Mueller-Eckhardt C. Clinical importance of granulocyte-specific antibodies. Beitr Infusionsther 1992;30:420-4. 15. Papadaki HA, Gibson FM, Rizzo S, Gordon- Smith EC, Marsh JC. Assessment of bone marrow stem cell reserve and function and stromal cell function in patients with autoimmune cytopenias. Blood 2000;96:3272-5. 16. Verheugt FW, von dem Borne AE, van Noord- Bokhorst JC, Engelfriet CP. Autoimmune granulocytopenia: the detection of granulocyte autoantibodies with the immunofluorescence test. Br J Haematol 1978;39:339-50. 17. Sella R, Flomenblit L, Goldstein I, Kaplinsky C. Detection of anti-neutrophil antibodies in autoimmune neutropenia of infancy: a multicenter study. Isr Med Assoc J 2010;12:91-6. 18. Currie MS, Weinberg JB, Rustagi PK, Logue GL. Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets. Blood 1987;69:529-36. 19. Hartman KR, LaRussa VF, Rothwell SW, Atolagbe TO, Ward FT, Klipple G. Antibodies to myeloid precursor cells in autoimmune neutropenia. Blood 1994;84:625-31. 20. Davoren A, Saving K, McFarland JG, Aster RH, Curtis BR. Neonatal neutropenia and bacterial sepsis associated with placental transfer of maternal neutrophil-specific autoantibodies. Transfusion 2004;44:1041-6. 21. Fung YL, Pitcher LA, Taylor K, Minchinton RM. Managing passively acquired autoimmune neonatal neutropenia: a case study. Transfus Med 2005;15:151-5. 22. Bux J, Jung KD, Mueller-Eckhardt G, Mueller-Eckhardt C. Granulocyte-specific and HLA antibodies in pregnancy: incidence and clinical value. Beitr Infusionsther 1992;30:446-9. 23. Bux J, Jung KD, Kauth T, Mueller-Eckhardt C. Serological and clinical aspects of granulocyte antibodies leading to alloimmune neonatal neutropenia. Transfus Med 1992;2: 143-9. 24. Dufour C, Farruggia P, Tucci F. Le neutropenie nel bambino. Area Pediatrica 2006;7. 25. Kobayashi M, Sato T, Kawaguchi H, et al. Efficacy of prophylactic use of trimethoprimsulfamethoxazole in autoimmune neutropenia in infancy. J Pediatr Hematol Oncol 2003;25: 553-7. 26. Roberts AW. G-CSF: a key regulator of neutrophil production, but that’s not all! Growth Factors 2005;23:33-41. 27. Hasegawa T, Suzuki K, Sakamoto C, et al. Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: upregulation of cIAP2 by granulocyte colonystimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia. Blood 2003;101:1164-71. 28. Dalhoff K, Hansen F, Drömann D, Schaaf B, Aries SP, Braun J. Inhibition of neutrophil apoptosis and modulation of the inflammatory response by granulocyte colony-stimulating factor in healthy and ethanol-treated human volunteers. J Infect Dis 1998;178:891-5. 29. Kuijpers TW, de Haas M, de Groot CJ, von dem Borne AE, Weening RS. The use of rhGCSF in chronic autoimmune neutropenia: reversal of autoimmune phenomena, a case history. Br J Haematol 1996;94:464-9. 30. Fioredda F, Calvillo M, Renga D, et al. Off-label use of granulocyte colony-stimulating factor in noncongenital neutropenia: retrospective data from the Italian Neutropenia Registry. Pediatr Hematol Oncol 2008;25:371-4. 31. Gilmore MM, Stroncek DF, Korones DN. Treatment of alloimmune neonatal neutropenia with granulocyte colony-stimulating factor. J Pediatr 1994;125:948-51. 32. Girlando P, Zuppa AA, Romagnoli C, Tortorolo G. Transient effect of granulocyte colony-stimulating factor in allo-immune neonatal neutropenia. Biol Neonate 2000;78: 277- 80. 33. Dungarwalla M, Marsh JC, Tooze JA, et al. Lack of clinical efficacy of rituximab in the treatment of autoimmune neutropenia and pure red cell aplasia: implications for their pathophysiology. Ann Hematol 2007;86:191-7. 34. Willis F, Marsh JC, Bevan DH, et al. The effect of treatment with Campath-1H in patients with autoimmune cytopenias. Br J Haematol 2001;114:891-8.